By Matt Chiappardi ( February 4, 2016, 9:26 PM EST) -- A Delaware bankruptcy judge let KaloBios' new management keep control Thursday of the drugmaker's Chapter 11, mounted two weeks after ousted CEO Martin Shkreli was charged with securities fraud, after hearing a potentially lucrative drug development deal, thought dead, was still on the table....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.